MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government_Funders & Regulators
*Government: U.S. Federal
Government: U.S. States & Territories
Government: States (U.S.)
Massachusetts
*Triple Helix Cluster & Developments: Massachusetts
*Industry: Massachusetts
Quanterix Corporation (NASDAQ: QTRX)*
Organization & Developments: Quanterix
Parents
Quanterix Corporation (NASDAQ: QTRX)*
Children
*Aims to expand the development of its SiMoA technology to enable simultaneous measurement of both nucleic acids and proteins for the detection of pathogens.
*Company’s Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ).
*Quanterix is developing and manufacturing a fully-automated instrument and low cost consumables for use in both the life sciences and in vitro diagnostics (IVD) markets.
2022: Quanterix partners with Lilly on Alzheimer's diagnostics
2023: Quanterix Corporation 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2023: Quanterix Corporation: Going For Three In A Row_seekingalpha.com
2024: Quanterix Corporation: Still Struggling To Gain Traction
2025: FDA greenlights first blood test to diagnose Alzheimer's disease
2025: Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
2025: Quanterix: Hard To Make A Good Diagnosis
2025: Quanterix: Why Pursuing A Big Deal For Akoya?
2026: Quanterix: No Green Shoots (NASDAQ:QTRX)
The Quanterix Revolution
Jumps
*Key People: Quanterix
Finance & Acquisition: Quanterix